About Maria Fardis
Maria Fardis is CEO and director at AirNexis Therapeutics.
Form D filings also name Maria Fardis as a director at Quanta Therapeutics.
Maria Fardis first appears on SEC filings in 2021.
Experience
This experience comes from Maria Fardis's profile and from SEC filings. For roles taken from filings, the years are when the filings name Maria Fardis in the role, so the role may have started earlier or lasted longer.
AirNexis Therapeutics, Inc. Current
Chief Executive Officer (2026 – Present)
Director
2026 – Present · Palo Alto, CA
Develops an inhaled treatment for people with chronic obstructive pulmonary disease.
CT
CRISPR Therapeutics Current
Member Board Of Directors
2022 – Present
Quanta Therapeutics, Inc. Current
Member Board of Directors
2021 – Present · South San Francisco, CA
Develops cancer medicines for patients with RAS-driven cancers.
OT
Obsidian Therapeutics Current
Chair Of The Board Of Directors
2021 – Present
FP
Frazier Healthcare Partners Current
Venture Partner
2021 – Present
LT
Lassen Therapeutics
Chief Executive Officer
2023 – 2026
KT
Kartos Therapeutics
Member Board Of Directors
2018 – 2021
II
Iovance Biotherapeutics, Inc.
President & Chief Executive Officer
2016 – 2021
AV
Acerta Pharma B.V.
Chief Operating Officer
2015 – 2016
PH
Pharmacyclics
Chief of Oncology Operations and Alliances
2011 – 2014
GS
Gilead Sciences
Associate Director, Project and Portfolio Management
2001 – 2011
IP
Intrabiotics Pharmaceuticals
Scientist, Medicinal Chemistry
2001
KS
Kosan Biosciences acquired by Brisol-Myers Squibb
Scientist, Medicinal Chemistry
1998 – 2000
UB
UC Berkeley
Graduate Student
1993 – 1998
Key Colleagues at Startups
The people Maria Fardis works with at each company, as listed on that company's latest Form D.
Quanta Therapeutics, Inc. · Form D/A, Jun 24, 2026
MK
Maha Katabi
Director
PN
Perry Nisen
Chief Executive Officer and director
CP
Cameron Pitt
Chief Operating Officer and director
YH
Ying Huang
Director
DM
Derek Metzger
Chief Strategy Officer
RJ
Rajul Jain
Director
AirNexis Therapeutics, Inc. · Form D, Mar 9, 2026
Anna Chen
Board Member
Colin Walsh
Board Member
Evan Caplan
Board Member
JL
James Li
Chair of the Board
Jill Carroll
Board Member